Year |
Citation |
Score |
2019 |
Kurowski A, Molotkov A, Soriano P. FGFR1 regulates trophectoderm development and facilitates blastocyst implantation. Developmental Biology. 446: 94-101. PMID 30552867 DOI: 10.1016/J.Ydbio.2018.12.008 |
0.656 |
|
2018 |
Molotkov A, Soriano P. Distinct mechanisms for PDGF and FGF signaling in primitive endoderm development. Developmental Biology. 442: 155-161. PMID 30026121 DOI: 10.1016/J.Ydbio.2018.07.010 |
0.768 |
|
2017 |
Molotkov A, Mazot P, Brewer JR, Cinalli RM, Soriano P. Distinct Requirements for FGFR1 and FGFR2 in Primitive Endoderm Development and Exit from Pluripotency. Developmental Cell. PMID 28552557 DOI: 10.1016/J.Devcel.2017.05.004 |
0.571 |
|
2015 |
Brewer JR, Molotkov A, Mazot P, Hoch RV, Soriano P. Fgfr1 regulates development through the combinatorial use of signaling proteins Genes & Development. 29: 1863-1874. PMID 26341559 DOI: 10.1101/Gad.264994.115 |
0.574 |
|
2013 |
Gandhi D, Molotkov A, Batourina E, Schneider K, Dan H, Reiley M, Laufer E, Metzger D, Liang F, Liao Y, Sun TT, Aronow B, Rosen R, Mauney J, Adam R, et al. Retinoid signaling in progenitors controls specification and regeneration of the urothelium. Developmental Cell. 26: 469-82. PMID 23993789 DOI: 10.1016/J.Devcel.2013.07.017 |
0.343 |
|
2010 |
Rosselot C, Spraggon L, Chia I, Batourina E, Riccio P, Lu B, Niederreither K, Dolle P, Duester G, Chambon P, Costantini F, Gilbert T, Molotkov A, Mendelsohn C. Non-cell-autonomous retinoid signaling is crucial for renal development. Development (Cambridge, England). 137: 283-92. PMID 20040494 DOI: 10.1242/Dev.040287 |
0.419 |
|
2009 |
Yamagami T, Molotkov A, Zhou CJ. Canonical Wnt signaling activity during synovial joint development. Journal of Molecular Histology. 40: 311-6. PMID 19921490 DOI: 10.1007/s10735-009-9242-1 |
0.481 |
|
2009 |
Song L, Li Y, Wang K, Wang YZ, Molotkov A, Gao L, Zhao T, Yamagami T, Wang Y, Gan Q, Pleasure DE, Zhou CJ. Lrp6-mediated canonical Wnt signaling is required for lip formation and fusion. Development (Cambridge, England). 136: 3161-71. PMID 19700620 DOI: 10.1242/dev.037440 |
0.496 |
|
2009 |
Zhao X, Sirbu IO, Mic FA, Molotkova N, Molotkov A, Kumar S, Duester G. Retinoic acid promotes limb induction through effects on body axis extension but is unnecessary for limb patterning. Current Biology : Cb. 19: 1050-7. PMID 19464179 DOI: 10.1016/j.cub.2009.04.059 |
0.305 |
|
2008 |
Zhou CJ, Molotkov A, Song L, Li Y, Pleasure DE, Pleasure SJ, Wang YZ. Ocular coloboma and dorsoventral neuroretinal patterning defects in Lrp6 mutant eyes. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 237: 3681-9. PMID 18985738 DOI: 10.1002/dvdy.21770 |
0.325 |
|
2007 |
Molotkova N, Molotkov A, Duester G. Role of retinoic acid during forebrain development begins late when Raldh3 generates retinoic acid in the ventral subventricular zone. Developmental Biology. 303: 601-10. PMID 17207476 DOI: 10.1016/j.ydbio.2006.11.035 |
0.377 |
|
2005 |
Molotkov A, Molotkova N, Duester G. Retinoic acid generated by Raldh2 in mesoderm is required for mouse dorsal endodermal pancreas development. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 232: 950-7. PMID 15739227 DOI: 10.1002/dvdy.20256 |
0.326 |
|
2005 |
Molotkova N, Molotkov A, Sirbu IO, Duester G. Requirement of mesodermal retinoic acid generated by Raldh2 for posterior neural transformation. Mechanisms of Development. 122: 145-55. PMID 15652703 DOI: 10.1016/j.mod.2004.10.008 |
0.346 |
|
Low-probability matches (unlikely to be authored by this person) |
2006 |
Molotkov A, Molotkova N, Duester G. Retinoic acid guides eye morphogenetic movements via paracrine signaling but is unnecessary for retinal dorsoventral patterning. Development (Cambridge, England). 133: 1901-10. PMID 16611695 DOI: 10.1242/dev.02328 |
0.275 |
|
2003 |
Fan X, Molotkov A, Manabe S, Donmoyer CM, Deltour L, Foglio MH, Cuenca AE, Blaner WS, Lipton SA, Duester G. Targeted disruption of Aldh1a1 (Raldh1) provides evidence for a complex mechanism of retinoic acid synthesis in the developing retina. Molecular and Cellular Biology. 23: 4637-48. PMID 12808103 DOI: 10.1128/Mcb.23.13.4637-4648.2003 |
0.249 |
|
2012 |
Batourina E, Gandhi D, Mendelsohn CL, Molotkov A. Organotypic culture of the urogenital tract Methods in Molecular Biology (Clifton, N.J.). 886: 45-53. PMID 22639250 DOI: 10.1007/978-1-61779-851-1_5 |
0.242 |
|
2003 |
Duester G, Mic FA, Molotkov A. Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissue-specific metabolism to retinoic acid. Chemico-Biological Interactions. 143: 201-10. PMID 12604205 DOI: 10.1016/s0009-2797(02)00204-1 |
0.24 |
|
2010 |
Zhou H, Liu W, Su Y, Wei Z, Liu J, Kolluri SK, Wu H, Cao Y, Chen J, Wu Y, Yan T, Cao X, Gao W, Molotkov A, Jiang F, et al. NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling. Cancer Cell. 17: 560-73. PMID 20541701 DOI: 10.1016/J.Ccr.2010.04.023 |
0.233 |
|
2004 |
Mic FA, Molotkov A, Molotkova N, Duester G. Raldh2 expression in optic vesicle generates a retinoic acid signal needed for invagination of retina during optic cup formation. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 231: 270-7. PMID 15366004 DOI: 10.1002/dvdy.20128 |
0.232 |
|
2008 |
Wang YZ, Molotkov A, Song L, Li Y, Pleasure DE, Zhou CJ. Activation of the Wnt/β-catenin signaling reporter in developing mouse olfactory nerve layer marks a specialized subgroup of olfactory ensheathing cells Developmental Dynamics. 237: 3157-3168. PMID 18816448 DOI: 10.1002/dvdy.21712 |
0.223 |
|
2000 |
Mic FA, Molotkov A, Fan X, Cuenca AE, Duester G. RALDH3, a retinaldehyde dehydrogenase that generates retinoic acid, is expressed in the ventral retina, otic vesicle and olfactory pit during mouse development Mechanisms of Development. 97: 227-230. PMID 11025231 DOI: 10.1016/S0925-4773(00)00434-2 |
0.221 |
|
2002 |
Molotkov A, Deltour L, Foglio MH, Cuenca AE, Duester G. Distinct retinoid metabolic functions for alcohol dehydrogenase genes Adh1 and Adh4 in protection against vitamin A toxicity or deficiency revealed in double null mutant mice Journal of Biological Chemistry. 277: 13804-13811. PMID 11836246 DOI: 10.1074/jbc.M112039200 |
0.2 |
|
2002 |
Molotkov A, Fan X, Deltour L, Foglio MH, Martras S, Farrés J, Parés X, Duester G. Stimulation of retinoic acid production and growth by ubiquitously expressed alcohol dehydrogenase Adh3. Proceedings of the National Academy of Sciences of the United States of America. 99: 5337-42. PMID 11959987 DOI: 10.1073/pnas.082093299 |
0.192 |
|
2023 |
Tate T, Plumber SA, Al-Ahmadie H, Chen X, Choi W, Lu C, Viny A, Batourina E, Gartensson K, Alija B, Molotkov A, Wiessner G, McKiernan J, McConkey D, Dinney C, et al. Combined Mek inhibition and activation Eradicates Muscle Invasive Bladder cancer in a Mouse Model of BBN-induced Carcinogenesis. Biorxiv : the Preprint Server For Biology. PMID 37662238 DOI: 10.1101/2023.08.19.553961 |
0.19 |
|
2002 |
Molotkov A, Fan X, Duester G. Excessive vitamin A toxicity in mice genetically deficient in either alcohol dehydrogenase Adh1 or Adh3. European Journal of Biochemistry. 269: 2607-12. PMID 12027900 DOI: 10.1046/j.1432-1033.2002.02935.x |
0.19 |
|
2003 |
Mic FA, Molotkov A, Benbrook DM, Duester G. Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synthesis. Proceedings of the National Academy of Sciences of the United States of America. 100: 7135-40. PMID 12782789 DOI: 10.1073/Pnas.1231422100 |
0.176 |
|
2024 |
Rogava M, Aprati TJ, Chi WY, Melms JC, Hug C, Davis SH, Earlie EM, Chung C, Deshmukh SK, Wu S, Sledge G, Tang S, Ho P, Amin AD, Caprio L, ... ... Molotkov A, et al. Loss of Pip4k2c confers liver-metastatic organotropism through insulin-dependent PI3K-AKT pathway activation. Nature Cancer. PMID 38286827 DOI: 10.1038/s43018-023-00704-x |
0.166 |
|
2003 |
Molotkov A, Duester G. Genetic evidence that retinaldehyde dehydrogenase Raldh1 (Aldh1a1) functions downstream of alcohol dehydrogenase Adh1 in metabolism of retinol to retinoic acid. The Journal of Biological Chemistry. 278: 36085-90. PMID 12851412 DOI: 10.1074/jbc.M303709200 |
0.162 |
|
2002 |
Szalai G, Xie D, Wassenich M, Veres M, Ceci JD, Dewey MJ, Molotkov A, Duester G, Felder MR. Distal and proximal cis-linked sequences are needed for the total expression phenotype of the mouse alcohol dehydrogenase 1 (Adh1) gene. Gene. 291: 259-70. PMID 12095699 DOI: 10.1016/S0378-1119(02)00624-8 |
0.158 |
|
2014 |
Van Batavia J, Yamany T, Molotkov A, Dan H, Mansukhani M, Batourina E, Schneider K, Oyon D, Dunlop M, Wu XR, Cordon-Cardo C, Mendelsohn C. Bladder cancers arise from distinct urothelial sub-populations. Nature Cell Biology. 16: 982-91, 1-5. PMID 25218638 DOI: 10.1038/Ncb3038 |
0.132 |
|
2019 |
Molotkov A, Mela A, Canoll PD, Mintz A. CBMT-03. EVALUATION OF PET TRACERS TO DIFFERENTIATE IDH1 MUTANT GBM Neuro-Oncology. 21: vi33-vi33. DOI: 10.1093/neuonc/noz175.125 |
0.129 |
|
2002 |
Dalfó D, Albalat R, Molotkov A, Duester G, Gonzàlez-Duarte R. Retinoic acid synthesis in the prevertebrate amphioxus involves retinol oxidation. Development Genes and Evolution. 212: 388-93. PMID 12203095 DOI: 10.1007/S00427-002-0254-Z |
0.126 |
|
1995 |
Kabakov AE, Molotkov AO, Budagova KR, Mosin AF, Gabai VL. Adaptation of Ehrlich ascites carcinoma cells to energy deprivation in vivo can be associated with heat shock protein accumulation. Journal of Cellular Physiology. 165: 1-6. PMID 7559791 DOI: 10.1002/JCP.1041650102 |
0.117 |
|
2004 |
Molotkov A, Ghyselinck NB, Chambon P, Duester G. Opposing actions of cellular retinol-binding protein and alcohol dehydrogenase control the balance between retinol storage and degradation. The Biochemical Journal. 383: 295-302. PMID 15193143 DOI: 10.1042/Bj20040621 |
0.107 |
|
2002 |
Molotkov A, Duester G. Retinol/ethanol drug interaction during acute alcohol intoxication in mice involves inhibition of retinol metabolism to retinoic acid by alcohol dehydrogenase. The Journal of Biological Chemistry. 277: 22553-7. PMID 11960985 DOI: 10.1074/jbc.M201603200 |
0.103 |
|
2020 |
Molotkov A, Doubrovin M, Bhatt N, Hsu FC, Beserra A, Chopra R, Mintz A. 3D optical/CT as a preclinical companion imaging platform for glioblastoma drug development. Drug Delivery. 27: 1686-1694. PMID 33263448 DOI: 10.1080/10717544.2020.1833381 |
0.1 |
|
2004 |
Zabrodskii PF, Kirichuk VF, Germanchuk VG, Nodel' ML, Rush ML, Molotkov AO, Mal'tseva GM, Osipov OV. Suppression of natural killer cells after acute intoxication with alcohols and cholinotropic preparations and their reactivation with T-activin. Bulletin of Experimental Biology and Medicine. 135: 59-61. PMID 12717515 DOI: 10.1023/A:1023450013591 |
0.091 |
|
2022 |
Dileep Kumar JS, Molotkov A, Carberry P, Chaly T, Neelamegam R, Mintz A. Radiosynthesis and evaluation of [C]AG-488, a dual anti-angiogenetic and anti-tubulin PET ligand. Bioorganic & Medicinal Chemistry Letters. 74: 128941. PMID 35964845 DOI: 10.1016/j.bmcl.2022.128941 |
0.085 |
|
2001 |
Molotkov A, Satoh M, Tohyama C. Induction of hepatic metallothioneins in tumor-bearing IL-6-null mice. Oncology Research. 12: 169-72. PMID 11341465 DOI: 10.3727/096504001108747648 |
0.066 |
|
2020 |
Molotkov A, Castrillon JW, Santha S, Harris PE, Leung DK, Mintz A, Carberry P. The Radiolabeling of a Gly-Sar Dipeptide Derivative with Flourine-18 and Its Use as a Potential Peptide Transporter PET Imaging Agent. Molecules (Basel, Switzerland). 25. PMID 32024310 DOI: 10.3390/molecules25030643 |
0.065 |
|
2021 |
Prabhakaran J, Molotkov A, Mintz A, Mann JJ. Progress in PET Imaging of Neuroinflammation Targeting COX-2 Enzyme. Molecules (Basel, Switzerland). 26. PMID 34071951 DOI: 10.3390/molecules26113208 |
0.061 |
|
1999 |
Molotkov A, Satoh M, Tohyama C. Tumor growth and food intake in interleukin-6 gene knock-out mice. Cancer Letters. 132: 187-92. PMID 10397473 DOI: 10.1016/S0304-3835(98)00182-7 |
0.059 |
|
2000 |
Molotkov A, Nishimura N, Satoh M, Tohyama C. Role of IL-6 in the induction of hepatic metallothionein in mice after partial hepatectomy. Life Sciences. 66: 963-70. PMID 10724443 DOI: 10.1016/S0024-3205(99)00661-X |
0.059 |
|
1999 |
Anisimov VN, Kvetnoy IM, Chumakova NK, Kvetnaya TV, Molotkov AO, Pogudina NA, Popovich IG, Popuchiev VV, Zabezhinski MA, Bartsch H, Bartsch C. Melatonin and colon carcinogenesis. II. Intestinal melatonin-containing cells and serum melatonin level in rats with 1,2-dimethylhydrazine-induced colon tumors. Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie. 51: 47-52. PMID 10048713 DOI: 10.1016/S0940-2993(99)80062-1 |
0.057 |
|
2022 |
Kumar JSD, Molotkov A, Kim J, Carberry P, Idumonyi S, Castrillon J, Duff K, Shneider NA, Mintz A. Preclinical evaluation of a microtubule PET ligand [C]MPC-6827 in tau and amyotrophic lateral sclerosis animal models. Pharmacological Reports : Pr. PMID 35286710 DOI: 10.1007/s43440-022-00359-y |
0.057 |
|
2020 |
Molotkov A, Bhatt N, Doubrovin M, Castrillon J, Massa C, Gerber A, D'Armiento J, Goldklang M, Mintz A. Multimodality molecular imaging of the alveolar-capillary barrier in lung disease using albumin based optical and PET tracers. Molecular Biomedicine (Online). 1: 17. PMID 34766000 DOI: 10.1186/s43556-020-00020-1 |
0.052 |
|
2020 |
Molotkov A, Bhatt N, Doubrovin M, Castrillon J, Massa C, Gerber A, D’Armiento J, Goldklang M, Mintz A. Multimodality molecular imaging of the alveolar-capillary barrier in lung disease using albumin based optical and PET tracers Molecular Biomedicine. 1. DOI: 10.1186/s43556-020-00020-1 |
0.051 |
|
2020 |
Capaccione KM, Doubrovin M, Bhatt N, Mintz A, Molotkov A. Granzyme B PET Imaging of the Innate Immune Response. Molecules (Basel, Switzerland). 25. PMID 32646038 DOI: 10.3390/molecules25133102 |
0.046 |
|
1998 |
Suzuki JS, Kodama N, Molotkov A, Aoki E, Tohyama C. Isolation and identification of metallothionein isoforms (MT-1 and MT-2) in the rat testis. The Biochemical Journal. 695-701. PMID 9729479 DOI: 10.1042/BJ3340695 |
0.043 |
|
2021 |
Dileep Kumar JS, Molotkov A, Salling MC, Carberry P, Prabhakaran J, Castrillon J, Mintz A. In vivo evaluation of a microtubule PET ligand, [C]MPC-6827, in mice following chronic alcohol consumption. Pharmacological Reports : Pr. PMID 34491568 DOI: 10.1007/s43440-021-00311-6 |
0.04 |
|
2020 |
Kumar JSD, Prabhakaran J, Molotkov A, Sattiraju A, Kim J, Doubrovin M, Mann JJ, Mintz A. Radiosynthesis and evaluation of [F]FMTP, a COX-2 PET ligand. Pharmacological Reports : Pr. PMID 32632914 DOI: 10.1007/s43440-020-00124-z |
0.032 |
|
2021 |
Molotkov A, Carberry P, Dolan MA, Joseph S, Idumonyi S, Oya S, Castrillon J, Konofagou EE, Doubrovin M, Lesser GJ, Zanderigo F, Mintz A. Real-Time Positron Emission Tomography Evaluation of Topotecan Brain Kinetics after Ultrasound-Mediated Blood-Brain Barrier Permeability. Pharmaceutics. 13. PMID 33803856 DOI: 10.3390/pharmaceutics13030405 |
0.03 |
|
2022 |
Capaccione KM, Doubrovin M, Braumuller B, Leibowitz D, Bhatt N, Momen-Heravi F, Molotkov A, Kissner M, Goldner K, Soffing M, Ali A, Mintz A. Evaluating the Combined Anticancer Response of Checkpoint Inhibitor Immunotherapy and FAP-Targeted Molecular Radiotherapy in Murine Models of Melanoma and Lung Cancer. Cancers. 14. PMID 36230500 DOI: 10.3390/cancers14194575 |
0.026 |
|
2022 |
Alì A, Leibowitz D, Bhatt N, Doubrovin M, Spina CS, Bates-Pappas GE, Taub RN, McKiernan JM, Mintz A, Molotkov A. Preliminary efficacy of [Y]DOTA-biotin-avidin radiotherapy against non-muscle invasive bladder cancer. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36350400 DOI: 10.1007/s00259-022-06027-w |
0.017 |
|
2020 |
Nenasheva NM, Averyanov AV, Il'ina NI, Avdeev SN, Osipova GL, Rubanik TV, Zorin VN, Molotkov AO, Kuzubova NA, Kostina NE, Kudelya LM, Petrov DV. Comparative Study cf Biosimilar Genolar® Clinical Efficacy оп the Randomized Phase III Study Results Pulmonologiya. 30: 782-796. DOI: 10.18093/0869-0189-2020-30-6-782-796 |
0.01 |
|
2019 |
Fu J, Bhatt N, Kim J, Castrillon J, Carberry P, Molotkov A, Sanchorawala V, Connors L, Lentzsch S, Mintz A. Real-Time PET Imaging with Amyloid Fibril-Reactive Antibody CAEL-101 for Personalized AL Amyloidosis Immunotherapy Clinical Lymphoma Myeloma and Leukemia. 19: e314. DOI: 10.1016/J.Clml.2019.09.516 |
0.01 |
|
Hide low-probability matches. |